Top-News

Biostar Pharmaceuticals News

Aktie
WKN:  A2ACWH ISIN:  US0906783016 US-Symbol:  BSPM
-    $
+0,00 $
0,00%
30.05.24 20:52:33
Handeln Depot/Watchlist
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website

Biostar Pharmaceuticals News

23.04.18 - PR Newswire
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice PR Newswire
21.02.18 - PR Newswire
Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform
Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform PR Newswire
07.02.18 - PR Newswire
Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification
Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification PR Newswire
04.12.17 - PR Newswire
Biostar Regains Compliance with NASDAQ Continued Listing Requirement
Biostar Regains Compliance with NASDAQ Continued Listing Requirement PR Newswire
20.11.17 - PR Newswire
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017 PR Newswire
15.11.17 - PR Newswire
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017 PR Newswire
13.04.17 - PR Newswire
Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2016
Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2016 PR Newswire
21.11.16 - PR Newswire
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended September 30, 2016
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended September 30, 2016 PR Newswire
18.10.16 - PR Newswire
Biostar Pharmaceuticals Completes Previously Announced Registered Direct Financing
Biostar Pharmaceuticals Completes Previously Announced Registered Direct Financing PR Newswire
12.10.16 - PR Newswire
Biostar Announces Execution of Agreement for $1.91 Million Registered Direct Offering of Shares of Common Stock and Warrants
Biostar Announces Execution of Agreement for $1.91 Million Registered Direct Offering of Shares of Common Stock and Warrants PR Newswire
11.10.16 - PR Newswire
Biostar to Launch a New Product Aimed at Treating Effects of Rhinitis and Sinusitis
Biostar to Launch a New Product Aimed at Treating Effects of Rhinitis and Sinusitis PR Newswire
22.09.16 - PR Newswire
Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng Health Products Co., Ltd.
Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng Health Products Co., Ltd. PR Newswire
23.05.16 - PR Newswire
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2016
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2016 PR Newswire
14.04.16 - PR Newswire
Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2015
Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2015 PR Newswire
24.02.16 - PR Newswire
Biostar Pharmaceuticals Regains Compliance with NASDAQ $1.00 Minimum Bid Price
Biostar Pharmaceuticals Regains Compliance with NASDAQ $1.00 Minimum Bid Price PR Newswire
16.02.16 - PR Newswire
Biostar Pharmaceuticals Airs Advertisements for its Analgesic (Pain Relief) Cream on China's CCTV
Biostar Pharmaceuticals Airs Advertisements for its Analgesic (Pain Relief) Cream on China's CCTV PR Newswire
04.12.15 - PR Newswire
Biostar Pharmaceuticals Inc. Postpones its 2015 Annual Meeting of Shareholders
Biostar Pharmaceuticals Inc. Postpones its 2015 Annual Meeting of Shareholders PR Newswire
23.11.15 - PR Newswire
BiostarPharmaceuticals,Inc. Announces Its Quarterly Results for Three Months Ended September 30, 2015
BiostarPharmaceuticals,Inc. Announces Its Quarterly Results for Three Months Ended September 30, 2015 PR Newswire
27.08.14 - PR Newswire
Biostar Pharmaceuticals Inc. Engaged Chief Scientist Professor Xiaohui Zheng To Preside Over The Company's Product Development Projects
Biostar Pharmaceuticals Inc. Engaged Chief Scientist Professor Xiaohui Zheng To Preside Over The Company's Product Development Projects PR Newswire
14.08.14 - PR Newswire
Biostar Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results
Biostar Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results -- Revenue increased by 31% to $19.2 million -- Net income increased to $1.65 million as ...

Newssuche

Videos

newspaper
29.05.24 +17,26%
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »